Whalesbook
New Tariff Hurdles for US-India Trade Deal
The upcoming June 1-4 visit by U.S. negotiators is a critical moment for economic talks between the two nations. While the goal is to finalize an interim trade deal, recent U.S. policy changes have complicated the framework agreed upon in February. The introduction of a universal 10% tariff on all imports in late February has made it difficult to proceed with earlier tariff reduction offers. The U.S. delegation, led by Brendan Lynch, must find a way to adjust proposals without causing political problems in either country.
Strategic Supply Chains and Security
Beyond tariffs, these discussions reflect a shift in global supply chains towards greater economic security. By establishing a framework for critical minerals, both the U.S. and India aim to reduce reliance on countries like China for refining. This focus on critical minerals is a key strategy for economic safety. India's commitment to spend $500 billion on U.S. energy, aircraft, and technology over the next five years serves as an incentive for the U.S. to offer better market access for Indian agricultural and industrial goods.
Economic Risks and Trade Balance
The main risk to the trade agreement is the gap between what is said and what is economically feasible. India had a strong trade surplus of $34.4 billion in 2025-26, but imports from the U.S. surged by 15.95%, showing a growing demand for American products that high tariffs could limit. The focus on an 'interim' pact also suggests neither country is ready for a full free trade agreement, raising questions about its long-term viability. If the U.S. maintains its 10% tariff, India's willingness to lower its own tariffs on agricultural products like red sorghum and soybean oil will likely decrease.
What to Watch For
Progress in customs facilitation is the most probable outcome to monitor. If the negotiations do not resolve the 10% tariff difference, the bilateral relationship could shift from a unified trade framework to sector-specific disputes. Analysts are cautious, suggesting that failure to agree on tariffs might lead to retaliatory measures in the technology and pharmaceutical sectors, potentially impacting the record trade volumes seen last fiscal year.